11682 EL CAMINO REAL, SUITE 120, SAN DIEGO, CA
Investor Presentation
Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)
News, Material Contracts
Other Events
Reports Second Quarter 2025 Financial Results and Highlights Accelerating Growth for neffy® (epinephrine nasal spray)
Shareholder votes
Reports First Quarter 2025 Financial Results and Highlights Progress in U.S. Commercial Launch of neffy® (epinephrine nasal spray)
Material Contracts
FY 2025
Q3
Q2
Q1
FY 2024
Q3 amended
Registration Statement for Securities to be Offered to Employees
S-3ASR
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Submission Upload
Correspondence